Publications
203
Citations
2,192
Est. group size
—
Recurring co-author estimate
Active years
47
Publishing since 1980
The publication record associated with this profile spans two quite different areas: biomedical cancer research (particularly brain tumors such as diffuse midline glioma and medulloblastoma, including antibody and molecular-targeting studies) and computational/data science topics (machine learning for weather forecasting and cardiovascular risk prediction, search algorithms for large datasets, and IoT cybersecurity). The work involves both laboratory biology and applied artificial intelligence and data-management methods.
Publication counts fluctuate sharply year to year, with peaks in 2020, 2023, and 2025, indicating uneven but overall active output rather than a steady rate.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Multi-Scale Temporal Contrastive Learning for Accurate Weather Forecasting
2026
- Convolution Tool
HubZero · 2026
- Telescope indexing for k-nearest neighbor search algorithms over high dimensional data & large data sets
Scientific Reports · 2025
- Optimized Hyperspectral Crop Classification using Coot Bird Algorithm
2025
- Supplementary Figure S1 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma
2025
- Supplementary Table S1 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma
2025
- Supplementary Figure S5 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma
2025
- Supplementary Figure S9 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma
2025
- Supplementary Figure S7 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma
2025
- Supplementary Figure S10 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma
2025
- Supplementary FIgure S4 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma
2025
- Key Resource Table from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma
2025
- Supplementary Figure S3 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma
2025
- Supplementary Figure S6 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma
2025
- Supplementary Table S3 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma
2025
- Neuro-Oncology×27
- Cell Reports×3
- Cancer Research×2
- Journal of Engineering Education×2
- bioRxiv (Cold Spring Harbor Laboratory)×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile